ADD-ON ABLATION SURGERY IN PATIENTS WITH ATRIAL FIBRILLATION

Page 90 - ADD-ON ABLATION SURGERY IN PATIENTS WITH ATRIAL FIBRILLATION

P. 90

Chapter 9
40. Fair and sustainable care (in Dutch).The Council for Public Health and Health Care, 2006.
41. Kottkamp H, Hindricks G, Hammel D, Breithardt G, Mohr FW, Scheld HH.et al. Intraoperative radiofrequency ablation of chronic atrial fibrillation:A left atrial curative approach by elimination of anatomic ‘anchor’ reentrant circuits. J Cardiovasc Electrophysiol 1999; 10:772-780.
42. Magnano AR, Argenziano M, Dizon JM, Vigilance D, Williams M, Yegen H, et al. Mechanisms of atrial tachyarrhythmias following surgical atrial fibrillation ablation. J Cardiovasc Electrophysiol 2006; 17:366–73.
43. IshiiY,GlevaMJ,GamacheMC,SchuesslerRB,BoineauJP,BaileyMS,etal.Atrialtachyarrhythmiasafter the maze procedure: incidence and prognosis. Circulation 2004; 110: II 164–II168.
44. Cox JL. Intraoperative options for treating atrial fibrillation associated with mitral valve disease. J Thorac Cardiovasc Surg 2001; 122:212-215.
45. Maroto LC, Carnero M, Silva JA, Cobiella J, Pérez-Castellano N, Reguillo F,et al. Early recurrence is a predictor of late failure in surgical ablation of atrial fibrillation. Interact Cardiovasc Thorac Surg 2011;12:681-686.
46. Crijns HJ,Van Gelder IC,Van Gilst WH, Hillege H, Gosselink AM, Lie KL. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.Am J Cardiol 1991; 68: 335-41.
47. Gosselink ATM, Crijns HJGM,Van Gelder IC, Hillige H,Wiesfeld ACP, Lie KI. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. J Am Med Ass 1992; 267: 3289–93.
48. Podrid PJ. Amiodarone: re-evaluation of an old drug. Ann Intern Med 1995; 122: 689-700.
49. Kim JB, Ju MH,Yun SC, Jung SH, Chung CH, Choo SJ,et al. Mitral valve replacement with or without a concomitant Maze procedure in patients with atrial fibrillation. Heart. 2010; 96:1126-1131.
50. Ad N, Henry R, Hunt S, Holmes SD. Impact of Clinical Presentation and Surgeon Experience on the Decision to Perform Surgical Ablation. Ann Thorac Surg. 2013; 96(3): 763-8.
51. Gage BF.Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285:2864-2870.
52. Pisters R, de Vos CB, Nieuwlaat R, Crijns HJ. Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms. Seminars in thrombosis and hemostasis 2009; 35:554-559.
53. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012; 9:632-696.
54. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, et al; Heart Rhythm Society; European Heart Rhythm Association; European Cardiac Arrhythmia Society; American College of Cardiology; American Heart Association; Society of Thoracic Surgeons. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up.A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace 2007; 9: 335–379.
208

88 89 90 91 92